Effects of Schema Therapy vs. Cognitive Behavioral Therapy vs. Individual Supportive Therapy

计划入组 300 人 · 首次发布于 2017 年 9 月 19 日

Evolutionary Therapy for Rhabdomyosarcoma

计划入组 12 人 · 首次发布于 2020 年 5 月 14 日

A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute

计划入组 105 人 · 首次发布于 2008 年 12 月 19 日

β-Secretase inhibitor(Max Planck Institute)

Abrineurin (Max Planck Institute of Experimental Medicine)

NY-ESO-1 nanovaccine (Max Planck Institute)

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

Germany

MAX HEALTHCARE INSTITUTE LIMITED

India

The Institute For Transfusion Medicine

United States

Large-Scale Drug Screen Reveals Common Medicines Can Enhance CRISPR Therapy and Target DNA Repair-Deficient Cancers

QLi5 Therapeutics Secures €6.2M to Advance Novel Proteasome Inhibitor ADC Platform

Nanoscope Therapeutics Enhances Vision Restoration Therapy with CatCh Technology License